https://pharminent.com/fda-approves-jjs-imaavy-for-warm-autoimmune-hemolytic-anemia-the-first-therapy-ever-cleared-in-the-disease/ 2026-08-25T20:25:15Z Pharminent en FDA Approves J&J's Imaavy for Warm Autoimmune Hemolytic Anemia, the First Therapy Ever Cleared in the Disease 2026-08-25T20:25:11Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-august-25-2026/ 2026-08-25T17:32:01Z Pharminent en Strategic News Watch • August 25, 2026 2026-08-25T17:31:59Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-august-24-2026/ 2026-08-25T15:22:45Z Pharminent en Rare Disease & Gene Therapy Digest • August 24, 2026 2026-08-25T15:22:43Z Blog https://pharminent.com/week-in-review/week-in-review-intelligence-brief-august-22-2026/ 2026-08-25T15:19:22Z Pharminent en Week in Review • INTELLIGENCE BRIEF • August 22, 2026 2026-08-25T15:19:04Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-august-21-2026/ 2026-08-25T15:17:29Z Pharminent en Oncology Intelligence Digest • August 21, 2026 2026-08-25T15:17:27Z Blog https://pharminent.com/bausch-lomb-advances-dry-eye-disease-drug-to-phase-3-despite-mid-stage-fail/ 2026-08-25T18:04:17Z Pharminent en Bausch + Lomb advances dry eye disease drug to Phase 3 despite mid-stage fail 2026-08-25T11:57:39Z Blog https://pharminent.com/fda-greenlights-roches-biomarker-blood-test-for-alzheimers/ 2026-08-25T18:04:37Z Pharminent en FDA greenlights Roche's biomarker blood test for Alzheimer's 2026-08-25T10:22:21Z Blog https://pharminent.com/fda-places-clinical-hold-on-regenxbios-rgx-121-in-mps-ii-trial/ 2026-08-25T18:05:02Z Pharminent en FDA places clinical hold on Regenxbio's RGX-121 in MPS II trial 2026-08-25T09:21:58Z Blog https://pharminent.com/genentech-licenses-hanmis-muscle-sparing-obesity-drug-in-deal-worth-up-to-2-3-billion/ 2026-08-24T21:12:09Z Pharminent en Genentech Licenses Hanmi's Muscle-Sparing Obesity Drug in Deal Worth Up to $2.3 Billion 2026-08-24T20:39:44Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-august-24-2026/ 2026-08-24T20:33:51Z Pharminent en Strategic News Watch • August 24, 2026 2026-08-24T20:33:48Z Blog https://pharminent.com/roche-commits-to-lean-mass-preservation-with-hanmi-obesity-deal/ 2026-08-25T17:13:40Z Pharminent en Roche commits to lean-mass preservation with Hanmi obesity deal 2026-08-24T13:47:31Z Blog https://pharminent.com/glp-1-competitive-market/glp-1-competitive-market-digest-weekly-august-21-2026/ 2026-08-23T14:21:38Z Pharminent en GLP-1 Competitive Market Digest • Weekly • August 21, 2026 2026-08-23T14:21:36Z Blog